<PAGE>

EXHIBIT 31.1

   CERTIFICATION REQUIRED BY SECTION 302(A) OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph Frattaroli, certify that:

      1.    I have reviewed this Quarterly Report on Form 10-QSB of Vaso Active
            Pharmaceuticals, Inc.;

      2.    Based on my knowledge, this report does not contain any untrue
            statement of a material fact or omit to state a material fact
            necessary to make the statements made, in light of the circumstances
            under which such statements were made, not misleading with respect
            to the period covered by this report;

      3.    Based on my knowledge, the financial statements, and other financial
            information included in this report, fairly present in all material
            respects the financial condition, results of operations and cash
            flows of the small business issuer as of, and for, the periods
            presented in this report;

      4.    I am responsible for establishing and maintaining disclosure
            controls and procedures (as defined in Exchange Act Rules 13a-15(e)
            and 15d-15(e)) for the small business issuer and have:

                (a)   Designed such disclosure controls and procedures, or
                      caused such disclosure controls and procedures to be
                      designed under our supervision, to ensure that material
                      information relating to the small business issuer is made
                      known to us by others within those entities, particularly
                      during the period in which this report is being prepared;

                (b)   Evaluated the effectiveness of the small business issuer's
                      disclosure controls and procedures and presented in this
                      report our conclusions about the effectiveness of the
                      disclosure controls and procedures, as of the end of the
                      period covered by this report based on such evaluation;
                      and

                (c)   Disclosed in this report any change in the small business
                      issuer's internal control over financial reporting that
                      occurred during the small business issuer's most recent
                      fiscal quarter (the small business issuer's fourth fiscal
                      quarter in the case of an annual report) that has
                      materially affected, or is reasonably likely to materially
                      affect, the small business issuer's internal control over
                      financial reporting; and

      5.    I have disclosed, based on my most recent evaluation of internal
            control over financial reporting, to the small business issuer's
            auditors and the audit committee of the small business issuer's
            board of directors (or persons performing the equivalent functions):

                (a)   All significant deficiencies and material weaknesses in
                      the design or operation of internal control over financial
                      reporting which are reasonably likely to adversely affect
                      the small business issuer's ability to record, process,
                      summarize and report financial information; and

                (b)   Any fraud, whether or not material, that involves
                      management or other employees who have a significant role
                      in the small business issuer's internal control over
                      financial reporting.

August 21, 2006

By: /s/ Joseph Frattaroli
   -----------------------
Acting Chief Executive Officer (principal executive officer)
Chief Financial Officer (principal financial officer)